Kenegix Product 06
Natural health product licensed in Canada
- Other names
- Prime D+ with Caffeine (Piña Colada)
- Licence holder
- Real Ketones, LLC
- NPN or DIN-HM
- 80097227
- Status
- Active licence
- Licence date
- 21 February 2020
- Revision date
- 2 August 2021
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Saveur, Rébaudioside A, Betterave rouge, Silice, Acide citrique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Mesures | 1 Tous les jours |
Uses authorised in Canada
Source of caprylic acid, a medium chain fatty acid. Source of caprylic acid, a medium chain fatty acid, which contributes to energy metabolism and production. Source of caprylic acid, a medium chain fatty acid, which is a factor in energy metabolism and production. Source of Medium-Chain Fatty Acids which support energy production in the body. Source of Medium-Chain Fatty Acids, which metabolize into ketones, providing the body with an alternative source of energy. Source of Medium-chain fatty acids which metabolize into ketones, providing an alternative source of cellular energy to body tissues, including the brain and muscles. Helps (temporarily) to promote alertness, wakefulness, and endurance, relieve fatigue, and to enhance cognitive and motor performance. Used (temporarily) as a mild diuretic. Source of beta-hydroxybutyrate which increases blood beta-hydroxybutyrate levels and provides an alternative source of cellular energy (ATP) to body tissues.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are pregnant, breastfeeding, taking prescription medication or other natural health products, or if you have kidney disorders, diabetes, acute major illness such as myocardial infarction, cardiovascular disease or if you are on a low carbohydrate diet. This product provides 260-520 mg of sodium per day. This product contains caffeine consult a health care practitioner prior to use if you are taking lithium, if you have high blood pressure, glaucoma, and/or detrusor instability (overactive bladder syndrome). This product contains caffeine, consumption with natural health products (e.g. bitter orange extract, synephrine, octopamine, ephedra) or other drugs (e.g. ephedrine) which increase blood pressure and consumption with other caffeine-containing products (e.g. medications, coffee, tea, colas, cocoa, guarana, maté) is not recommended. This product is not intended as a substitute for sleep. Caffeine has been shown to reduce blood flow to the heart muscle during exercise which might lead to cardiovascular complications such as chest pain, and irregular heartbeat even in healthy individuals. If those symptoms occur, stop use and consult a health care practitioner/health care provider/health care professional/doctor/physician. If you have cardiovascular disease, consult a health care practitioner prior to use.
- Contre-indications
Do not use with other potassium-containing supplements or with potassium-containing salt-substitutes.
- Effets indésirables connus
May cause nausea, vomiting, diarrhea, dizziness and/or abdominal cramps in which case discontinue use and consult a health care practitioner. Hypersensitivity/allergy is known to occur, in which case, discontinue use.
Source
Official Health Canada record, licence 80097227
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2021. Photograph the packaging to check whether it has changed. Photograph the packaging